News | May 24, 2024
BaseLaunch announces a new partnership with AbbVie
Further strengthens BaseLaunch's global pharma industry partnerships
Further strengthens BaseLaunch's global pharma industry partnerships
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
The study also met all secondary endpoints with a reduction in severity of VMS at weeks 4 and 12, a reduction in frequency of VMS at week 1 as well as improvements in sleep disturbances and menopause related quality of life
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Subscribe To Our Newsletter & Stay Updated
